Business Wire9h
Arrowhead Pharmaceuticals Announces Acceptance of New Drug Application by U.S. FDA of Plozasiran for the Treatment of Familial Chylomicronemia Syndrome
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that the U.S. Food and Drug Administration (FDA) has accepted ...
RFK Jr. petitioned FDA in 2021 to revoke authorization of all COVID vaccines
Robert F. Kennedy Jr., who's nominated to become the next health secretary, asked the federal government to revoke its ...
AstraZeneca Gets FDA Approval for Metastatic Breast Cancer Treatment Datroway
AstraZeneca said the U.S. Food and Drug Administration approved Datroway, a treatment for metastatic breast cancer developed in combination with Daiichi Sankyo.
FDA Accepts Arrowhead Pharmaceuticals' Drug Application for Genetic Disease Treatment
Arrowhead Pharmaceuticals said Friday that the Food and Drug Administration accepted the company's new drug application for its treatment of familial chylomicronemia syndrome, a severe and rare ...
US FDA approves AstraZeneca's drug for breast cancer
The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...
The National Law Review13h
FDA Revokes Authorization for the Use of Red Dye No. 3 in Food and Ingestible Drugs
On 15 January 2025, the US Food and Drug Administration (FDA) announced that it will revoke the color additive authorization ...
JD Supra14h
FDA Issues ACNU Final Rule Establishing New Requirements for Nonprescription Drugs with an Additional Condition for Nonprescription Use
The US Food and Drug Administration (FDA)’s recently issued final rule establishing application, labeling, and postmarketing reporting ...
Hosted on MSN15h
FDA beats EMA to most approved new drugs in 2024
On 15 January, the two agencies released respective lists of medicines approved last year. The FDA approved 50 novel drugs ...
Bill Ackman blasts FDA for taking long to ban Red No. 3
The Food and Drug Administration is facing some backlash from hedge fund manager Bill Ackman about how long it took to ban Red No. 3 from the U.S. supply chain.
Hosted on MSN17h
FDA launches medicine discount information drive for elderly
The Food and Drug Administration (FDA) is launching an information campaign to ensure that senior citizens take advantage of ...
verywellhealth18h
Pristiq vs. Effexor: How Do They Compare?
Pristiq (desvenlafaxine) and Effexor (venlafaxine) are SNRIs. Pristiq treats depression, while Effexor treats depression and ...
FDA's Suggested Change to Food Packaging Raises Concerns Among Experts
Newsweek spoke to experts about the FDA's suggestion to place nutrition information on the front of packaged foods.